ADAM-17 regulates endothelial cell morphology, proliferation, and in vitro angiogenesis
- 27 February 2009
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 380 (1), 33-38
- https://doi.org/10.1016/j.bbrc.2009.01.013
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- 5-HT2A Receptor Induces ERK Phosphorylation and Proliferation through ADAM-17 Tumor Necrosis Factor-α-converting Enzyme (TACE) Activation and Heparin-bound Epidermal Growth Factor-like Growth Factor (HB-EGF) Shedding in Mesangial CellsPublished by Elsevier BV ,2006
- Making the cut: Protease-mediated regulation of angiogenesisExperimental Cell Research, 2006
- Selective Modulation of Integrin-mediated Cell Migration by Distinct ADAM Family MembersV⃞Molecular Biology of the Cell, 2005
- Shedding light on ADAM metalloproteinasesTrends in Biochemical Sciences, 2005
- Inosculation of Tissue-Engineered Capillaries with the Host's Vasculature in a Reconstructed Skin Transplanted on MiceAmerican Journal of Transplantation, 2005
- HB-EGF Is a Potent Inducer of Tumor Growth and AngiogenesisCancer Research, 2004
- Stimulated Shedding of Vascular Cell Adhesion Molecule 1 (VCAM-1) Is Mediated by Tumor Necrosis Factor-α-converting Enzyme (ADAM 17)Published by Elsevier BV ,2003
- MT1-MMP Initiates Activation of pro-MMP-2 and Integrin αvβ3 Promotes Maturation of MMP-2 in Breast Carcinoma CellsExperimental Cell Research, 2001
- Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivoProceedings of the National Academy of Sciences of the United States of America, 2000
- Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-αNature, 1997